CVR: 26385180
Secondary names: SkinOcare ApS, STIK A ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity amounted to DKK 4,349,573.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med køb og salg af medicinalprodukter og anden hermed beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 812 t. | -167 t. | 5.7 mio. | 4.3 mio. | 1 | |
| 2024 | 1.9 mio. | 271 t. | 7.1 mio. | 5.5 mio. | 1 | |
| 2023 | 2 mio. | 1 mio. | 6.8 mio. | 5.7 mio. | 1 | |
| 2022 | 1.8 mio. | 680 t. | 6 mio. | 4.9 mio. | 1 | |
| 2021 | 1.8 mio. | 618 t. | 5.3 mio. | 4.3 mio. | 1 | |
| 2020 | 1.2 mio. | 281 t. | 5.2 mio. | 3.8 mio. | 1 | |
| 2019 | 1.8 mio. | 818 t. | 4.3 mio. | 3.6 mio. | 1 | |
| 2018 | 1.1 mio. | 360 t. | 3.7 mio. | 2.9 mio. | 1 | |
| 2017 | 338 t. | -261 t. | 3.2 mio. | 2.6 mio. | 1 | |
| 2016 | 479 t. | -94 t. | 3.9 mio. | 2.8 mio. | 1 | |
| 2015 | 822 t. | 57 t. | 3.7 mio. | 2.9 mio. | - | |
| 2014 | 926 t. | 200 t. | 3.5 mio. | 2.9 mio. | - | |
| 2013 | 1.4 mio. | 416 t. | 3.4 mio. | 2.8 mio. | - | |
| 2012 | 1.6 mio. | 737 t. | 3.6 mio. | 2.9 mio. | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 413 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
PHARMAVEST ApS has published its annual report for 2025. Gross profit came to DKK 812,233, and the net result was DKK -167,231.
PHARMAVEST ApS has published its annual report for 2024. Gross profit came to DKK 1,925,932, and the net result was DKK 271,222.
PHARMAVEST ApS has published its annual report for 2023. Gross profit came to DKK 1,975,235, and the net result was DKK 1,013,388.
PHARMAVEST ApS has published its annual report for 2022. Gross profit came to DKK 1,770,660, and the net result was DKK 680,459.
PHARMAVEST ApS has published its annual report for 2021. Gross profit came to DKK 1,761,839, and the net result was DKK 617,952.
As of September 17, 2021, Frank Orluff Lydig Kristensen has left the board of directors of PHARMAVEST ApS.
As of September 17, 2021, Aage Madsen has left the board of directors of PHARMAVEST ApS.
As of September 17, 2021, Torben Vilsgaard has left the board of directors of PHARMAVEST ApS.
PHARMAVEST ApS has published its annual report for 2020. Gross profit came to DKK 1,159,046, and the net result was DKK 281,262.
PHARMAVEST ApS has published its annual report for 2019. Gross profit came to DKK 1,771,479, and the net result was DKK 817,782.
PHARMAVEST ApS has published its annual report for 2018. Gross profit came to DKK 1,085,349, and the net result was DKK 360,195.
PHARMAVEST ApS has published its annual report for 2017. Gross profit came to DKK 338,180, and the net result was DKK -260,711.
As of October 16, 2017, FRANK LYDIG HOLDING ApS is registered as an owner of PHARMAVEST ApS with an ownership share of 100%.
PHARMAVEST ApS has published its annual report for 2016. Gross profit came to DKK 479,261, and the net result was DKK -94,474.
As of December 2, 2016, Aage Madsen has joined the board of directors of PHARMAVEST ApS.
As of November 3, 2016, Anders Nicolai Petri has left the board of directors of PHARMAVEST ApS.
As of May 1, 2016, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of PHARMAVEST ApS.
As of May 1, 2016, MJAKP P/S has stepped down as auditor of PHARMAVEST ApS.
PHARMAVEST ApS has published its annual report for 2015. Gross profit came to DKK 822,086, and the net result was DKK 56,595.
As of July 20, 2015, Anders Nicolai Petri has joined the board of directors of PHARMAVEST ApS.
As of July 20, 2015, Torben Vilsgaard has joined the board of directors of PHARMAVEST ApS.
As of July 20, 2015, Niels Christian Schou has left the board of directors of PHARMAVEST ApS.
As of July 20, 2015, Ulla Yde has left the board of directors of PHARMAVEST ApS.
As of May 28, 2015, Frank Orluff Lydig Kristensen has joined the board of directors of PHARMAVEST ApS.
As of May 28, 2015, Niels Christian Schou has joined the board of directors of PHARMAVEST ApS.
As of May 28, 2015, Ulla Yde has joined the board of directors of PHARMAVEST ApS.
As of May 28, 2015, Frank Orluff Lydig Kristensen is registered as adm. dir. of PHARMAVEST ApS.
As of May 27, 2015, Frank Orluff Lydig Kristensen has stepped down as director of PHARMAVEST ApS.
PHARMAVEST ApS has published its annual report for 2014. Gross profit came to DKK 926,252, and the net result was DKK 199,954.
PHARMAVEST ApS has published its annual report for 2013. Gross profit came to DKK 1,435,221, and the net result was DKK 415,767.
PHARMAVEST ApS has published its annual report for 2012. Gross profit came to DKK 1,641,777, and the net result was DKK 736,953.
As of January 1, 2013, MJAKP P/S has been appointed auditor of PHARMAVEST ApS.
As of December 31, 2012, MJAKP2 I/S has stepped down as auditor of PHARMAVEST ApS.
As of January 1, 2007, MJAKP2 I/S has been appointed auditor of PHARMAVEST ApS.
As of January 1, 2007, Revisionsfirmaet Villy Pedersen I/S has stepped down as auditor of PHARMAVEST ApS.
As of April 15, 2004, Frank Orluff Lydig Kristensen is registered as director of PHARMAVEST ApS.
As of April 15, 2004, Regner Lydig Kristensen has stepped down as director of PHARMAVEST ApS.
As of May 21, 2002, Revisionsfirmaet Villy Pedersen I/S has been appointed auditor of PHARMAVEST ApS.
As of May 21, 2002, Harry Aamann has stepped down as auditor of PHARMAVEST ApS.
As of May 21, 2002, Regner Lydig Kristensen is registered as director of PHARMAVEST ApS.
As of May 21, 2002, Preben Bang Henriksen has stepped down as director of PHARMAVEST ApS.
As of January 1, 2002, Harry Aamann has been appointed auditor of PHARMAVEST ApS.
As of January 1, 2002, Preben Bang Henriksen is registered as director of PHARMAVEST ApS.
PHARMAVEST ApS was founded on January 1, 2002.
Companies in the same industry and area
CVR 45726738
CVR 32049478
CVR 36900709
CVR 39720213
CVR 83744014